Dasatinib‐induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review

Dasatinib‐induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review

Abstract Dasatinib is a potent and effective second‐generation oral tyrosine kinase inhibitor that is clinically indicated for the treatment of imatinib‐resistant or imatinib‐intolerant breakpoint cluster region‐Abelson (BCR‐ABL)‐positive chronic myeloid leukaemia (CML) or for Philadelphia chromosom...

Full description

Bibliographic Details
Main Authors: Chao‐Chin Hsu, Jui‐Feng Hsu, Kuan‐Li Wu
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Respirology Case Reports
Subjects:
Chronic myeloid leukaemia
chylothorax
dasatinib
Online Access:https://doi.org/10.1002/rcr2.753

Similar Items

Similar Items